CIK 0001703057
- Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,366,800
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,366,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +53,500 | $14.74 | $789K | 53,500 |
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +14,000 | $14.61 | $205K | 130,959 |
| 2021-06-09 | Booth Andrew Chief Financial Officer | Sale | −1,200,000 | $25.50 | $30.6M | 0 |
| 2021-06-07 | Booth Andrew Chief Financial Officer | Exercise or conversion | +600,000 | $0.19 | $114K | 600,000 |
| 2021-06-07 | Booth Andrew Chief Financial Officer | Exercise or conversion | +600,000 | $0.32 | $192K | 1,200,000 |
| 2021-06-07 | Booth Andrew Chief Financial Officer | Exercise or conversion · Share Option (right to buy) | −600,000 | 300,000 | ||
| 2021-06-07 | Booth Andrew Chief Financial Officer | Exercise or conversion · Share Option (right to buy) | −600,000 | 4,950,000 |
Page 2 of 2 · 27 trades